GSK
GSK (NYSE)
Dividend yield
3.62%
Distribution
Quarterly
1-Year Return
37.12%
5-Year Return
29.93%
Pros:
- Higher dividend yield compared to many healthcare stocks
- Strong market presence in vaccines and specialty medicines
Cons:
- Market volatility risk
- Dependence on successful drug development
GSK (GSK) may be suitable for long-term investors seeking exposure to the healthcare sector, particularly those interested in dividend income given its yield of approximately 3.6%. The stock has demonstrated solid returns over the past year and five years, which could appeal to those looking for both growth and income potential in their portfolio.